Correcting Independent 3rd-Party "Misinformation" About Prescription Drugs: Eliminate the "Influence Prong," Says Pharma Industry. This article summarizes the industry's response to the second guidance document regarding correcting and/or responding to misinformation related to a firm's own FDA-approved products when that information is created or disseminated by independent third parties on the Internet or through social media.
Xifaxan TV DTC "Bubble Guts" Character Is Creepy: Another Reason to Ban Ads?
Pharma Marketing Blog: Did Pawn Star Rick Harrison Ask His Daddy About the Value of Vascepa Omega-3 Fish Oil?
Pfizer has a Gold Mine in Sermo! Here's what Pfizer can learn through its Sermo deal: Which docs on Sermo are our friends? Which ones have the highest ratings among other Sermo docs and therefore are likely to be influential? Which docs seem interested in becoming consultants or doing clinical trials? http://pharmamkting.blogspot.com/2007/10/pfizer-has-gold-mine-in-sermo.html